Comparative Pharmacology
Head-to-head clinical analysis: EMPRACET W CODEINE PHOSPHATE 3 versus QOLIANA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EMPRACET W CODEINE PHOSPHATE 3 versus QOLIANA.
EMPRACET W/ CODEINE PHOSPHATE #3 vs QOLIANA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Codeine is a prodrug metabolized to morphine, which acts as a mu-opioid receptor agonist. Acetaminophen inhibits cyclooxygenase (COX) and modulates descending serotonergic pathways, providing analgesia and antipyresis.
QOLIANA (elagolix) is a nonpeptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist that competitively binds to GnRH receptors in the pituitary gland, thereby reducing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to decreased ovarian production of estrogen and progesterone, resulting in a hypoestrogenic state.
One or two tablets (300 mg acetaminophen / 30 mg codeine phosphate per tablet) orally every 4 hours as needed for pain, not to exceed 12 tablets per day.
Initiate at 5 mg orally once daily, increase as tolerated to 10 mg once daily. Maximum dose 20 mg once daily.
None Documented
None Documented
Acetaminophen: 2-3 hours; codeine: 2.5-3 hours; both prolonged in hepatic impairment; clinical context: dosing every 4-6 hours for acute pain.
Terminal elimination half-life is 12 hours (range 10–15 hours) in healthy adults; may extend to 18–24 hours in patients with moderate hepatic impairment (Child-Pugh B).
Acetaminophen is excreted renally as conjugates (glucuronide 60%, sulfate 30%, cysteine/mercapturate 8%), with <5% unchanged; codeine is metabolized to codeine-6-glucuronide (70%), norcodeine (10%), morphine (10%, via CYP2D6), and conjugates; renal excretion of metabolites; <15% of codeine excreted unchanged; fecal elimination minor.
Renal excretion of unchanged drug accounts for approximately 30% of elimination; biliary/fecal excretion accounts for 60% (including metabolites); 10% is metabolized with negligible pulmonary elimination.
Category D/X
Category C
Opioid Agonist
Opioid Agonist